Long-term follow-up trial of oral rifampin-cotrimoxazole combination versus intravenous cloxacillin in treatment of chronic Staphylococcal osteomyelitis

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 6, 2009, Pages 2672-2676

  Euba, G ^a   Murillo, O ^a   Fernandez Sabe N ^a   Mascaro J ^a,b   Cabo, J ^a   Perez A ^a   Tubau, F ^a   Verdaguer, R ^a   Gudiol, F ^a   Ariza, J ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b HOSPITAL MÚTUA DE TERRASSA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CLOXACILLIN; COTRIMOXAZOLE; OXACILLIN; RIFAMPICIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BRONCHOSPASM; CHRONIC OSTEOMYELITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEBRIDEMENT; FEMALE; FOLLOW UP; FOREIGN BODY; HUMAN; LENGTH OF STAY; LEUKOPENIA; MALE; MINIMUM INHIBITORY CONCENTRATION; NAUSEA; PATIENT COMPLIANCE; PHLEBITIS; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RASH; RELAPSE; STAPHYLOCOCCUS AUREUS; TREATMENT DURATION; VOMITING;

ADMINISTRATION, ORAL; ADULT; AGED; ANTI-INFECTIVE AGENTS; CLOXACILLIN; DRUG COMBINATIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; OSTEOMYELITIS; RIFAMPIN; STAPHYLOCOCCAL INFECTIONS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 67049145540     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01504-08     Document Type: Article

References (26)

1. Al-Maiyah, M., M. V. Hemmady, A. Shoaib, and R. L. Morgan-Jones. 2007. Recurrence of chronic osteomyelitis in a regenerated fibula after 65 years. Orthopedics 30:403-404. (Pubitemid 46860780)
2. Chuard, C., J. C. Lucet, P. Rohner, M. Herrmann, R. Auckenthaler, F. A. Waldvogel, and D. P. Lew. 1991. Resistance of Staphylococcus aureus recovered from infected foreign body in vivo to killing by antimicrobials. J. Infect. Dis. 163:1369-1373.
3. Clinical and Laboratory Standards Institute. 2007. Performance standards for antimicrobial susceptibility testing; 17th informational supplement. M100-S17. Clinical and Laboratory Standards Institute, Wayne, PA.
4. de Górgolas, M., P. Avilás, C. Verdejo, and M. L. Fernández Guerrero. 1995. Treatment of experimental endocarditis due to methicillin-susceptible or methicillin-resistant Staphylococcus aureus with trimethoprim-sulfamethoxazole and antibiotics that inhibit cell wall synthesis. Antimicrob. Agents Chemother. 39:953-957.
5. Drancourt, M., A. Stein, J. N. Argenson, R. Roiron, P. Groulier, and D. Raoult. 1997. Oral treatment of Staphylococcus spp. infected orthopaedic implants with fusidic acid or ofloxacin in combination with rifampicin. J. Antimicrob. Chemother. 39:235-240.
6. Drancourt, M., A. Stein, J. N. Argenson, A. Zannier, G. Curvale, and D. Raoult. 1993. Oral rifampin plus ofloxacin for treatment of Staphylococcus- infected orthopedic implants. Antimicrob. Agents Chemother. 37:1214-1218.
7. Elwell, L. P., H. R. Wilson, V. B. Knick, and B. R. Keith. 1986. In vitro and in vivo efficacy of the combination trimethoprim-sulfamethoxazole against clinical isolates of methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 29:1092-1094. (Pubitemid 16084076)
8. Gentry, L. O., and G. Rodriguez-Gomez. 1991. Ofloxacin versus parenteral therapy for chronic osteomyelitis. Antimicrob. Agents Chemother. 35:538-541.
9. Gentry, L. O., and G. G. Rodriguez. 1990. Oral ciprofloxacin compared with parenteral antibiotics in the treatment of osteomyelitis. Antimicrob. Agents Chemother. 34:40-43.
10. Kaka, A. S., A. M. Rueda, S. A. Shelburne III, K. Hulten, R. J. Hamill, and D. M. Musher. 2006. Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus. J. Antimicrob. Chemother. 58:680-683.
11. Kucers, A., S. M. Crowe, M. L. Grayson, and J. F. How. 1997. The use of antibiotics, 5th ed. Butterworth-Heinemann, Oxford, United Kingdom.
12. Lew, D. P., and F. A. Waldvogel. 1997. Osteomyelitis. N. Engl. J. Med. 336:999-1007.
13. Lew, D. P., and F. A. Waldvogel. 1999. Use of quinolones in osteomyelitis and infected orthopaedic prosthesis. Drugs 58(Suppl. 2):85-91. (Pubitemid 29500093)
14. Mader, J. T., C. Norden, J. D. Nelson, G. B. Calandra, et al. 1992. Evaluation of new anti-infective drugs for the treatment of osteomyelitis in adults. Clin. Infect. Dis. 15(Suppl. 1):S155-S161.
15. Markowitz, N., E. L. Quinn, and L. D. Saravolatz. 1992. Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection. Ann. Intern. Med. 117:390-398.
16. Norden, C. W. 1988. Lessons learned from animal models of osteomyelitis. Rev. Infect. Dis. 10:103-110.
17. Sanchez, C., A. Matamala, M. Salavert, E. Cuchi, M. Pons, F. Angles, and J. Garau. 1997. Cotrimoxazole plus rifampicin in the treatment of staphylococcal osteoarticular infection. Enferm. Infecc. Microbiol. Clin. 15:10-13. (In Spanish.)
18. Schrenzel, J., S. Harbarth, G. Schockmel, D. Genne, T. Bregenzer, U. Flueckiger, C. Petignat, F. Jacobs, P. Francioli, W. Zimmerli, and D. P. Lew. 2004. A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infection. Clin. Infect. Dis. 39:1285-1292.
19. Schwank, S., Z. Rajacic, W. Zimmerli, and J. Blaser. 1998. Impact of bacterial biofilm formation on in vitro and in vivo activities of antibiotics. Antimicrob. Agents Chemother. 42:895-898.
20. Senneville, E., Y. Yazdanpanah, M. Cazaubiel, M. Cordonnier, M. Valette, E. Beltrand, A. Khazarjian, L. Maulin, S. Alfandari, M. Caillaux, L. Dubreuil, and Y. Mouton. 2001. Rifampicin-ofloxacin oral regimen for the treatment of mild to moderate diabetic foot osteomyelitis. J. Antimicrob. Chemother. 48:927-930.
21. Waldvogel, F. A., and P. S. Papageorgiou. 1980. Osteomyelitis: the past decade. N. Engl. J. Med. 303:360-370.
22. Widmer, A., G. E. Barraud, and W. Zimmerli. 1988. Reactivation of Staphylococcus aureus osteomyelitis after 49 years. Schweiz. Med. Wochenschr. 118:23-26. (In German.)
23. Widmer, A. F., R. Frei, Z. Rajacic, and W. Zimmerli. 1990. Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections. J. Infect. Dis. 162:96-102.
24. Widmer, A. F., A. Gaechter, P. E. Ochsner, and W. Zimmerli. 1992. Antimicrobial treatment of orthopedic implant-related infections with rifampin combinations. Clin. Infect. Dis. 14:1251-1253.
25. Yeldandi, V., R. Strodtman, and J. R. Lentino. 1988. In-vitro and in-vivo studies of trimethoprim-sulphamethoxazole against multiple resistant Staphylococcus aureus. J. Antimicrob. Chemother. 22:873-880.
26. Zimmerli, W., A. F. Widmer, M. Blatter, R. Frei, P. E. Ochsner, et al. 1998. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. JAMA 279:1537-1541. (Pubitemid 28233008)